PTPRC and neoplasm: Tumor-associated macrophages (TAMs) are the most prominent innate immune cells in the TME, accounting for approximately 50% of CD45+ cells in the tumor tissue, with heterogeneity and plasticity ranging from antitumor to protumor [12].